Voyager Therapeutics Inc.
www.voyagertherapeutics.com
Latest From Voyager Therapeutics Inc.
Deal Watch: Xencor Adds New Bispecific Partner In Agreement With Genentech
Genentech will pay $120m up front to co-develop Xencor’s preclinical IL-15 candidate; deal also includes IL-15 R&D. Taiho licenses lung cancer candidate to Cullinan; Celgene and Triphase partner again.
Voyager Nabs Neurocrine As Partner In CNS Gene Therapy
Voyager signals Phase II study of gene therapy VY-AADC in Parkinson's disease is on track, with no expectations for regulatory setbacks.
J.P. Morgan 2019: Industry Throws A Bonanza, With An Elephant In The Room
Major deal news and exciting science lent boisterous vibe to industry's big meeting. But US drug pricing and macro political issues are factors industry can't ignore – even though it tried to.
J.P. Morgan 2019: Industry Throws A Bonanza, With An Elephant In The Room
Major deal news and exciting science lent a boisterous vibe to the drug industry's big annual business meeting. But US drug pricing and macro political issues are factors industry can't ignore – even though it tried to.
Company Information
- Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
-
Large Molecule
- Antibodies
- Synthesis Technologies, Production Processes
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Voyager Therapeutics Inc.
- Senior Management
-
Andre Turenne, Pres. & CEO
Alison Dorval, CFO
Omar Khwaja, MD, PhD, CMO
Matthew P Ottmer, COO
Dinah Sah, PhD, CSO - Contact Info
-
Voyager Therapeutics Inc.
Phone: (857) 259-5340
75 Sidney St.
Cambridge, MA 02139
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice